Korro Bio (KRRO) Other Accumulated Expenses (2018 - 2026)
Korro Bio's Other Accumulated Expenses came in at $105,000 for Q2 2026, down 19.2% from $130,000 a year earlier and down 40.0% from the prior quarter.
Korro Bio (KRRO) Other Accumulated Expenses (2018 - 2026) Analysis & Trends
At the end of FY2025, Korro Bio's Other Accumulated Expenses was $70,000, down 74.7% from FY2024.
- Other Accumulated Expenses carries a three-year compound annual growth rate of -30.3% (FY2022 to FY2025).
- Going back by year, Other Accumulated Expenses was $277,000 in FY2024 (-38.0%), $447,000 in FY2023 (+115.9%) and $207,000 in FY2022.
- The five-year range for quarterly Other Accumulated Expenses is $70,000 (Q4 2025) to $493,000 (Q1 2025).
- Year-over-year, Other Accumulated Expenses has declined for five consecutive quarters, with an average decline of 4.6% over the last seven quarters.
- The fastest year-over-year change in Other Accumulated Expenses over five years came in Q1 2025 (growth of 252.1%), and the weakest in Q4 2025 (a decline of 74.7%).
- Business Quant data shows KRRO's Other Accumulated Expenses at $175,000 (Q1 2026), $70,000 (Q4 2025) and $111,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Korro Bio | 141.76 Mn | -254.88 Mn | - |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 105,000.00 |
| Mar 31, 2026 | 175,000.00 |
| Dec 31, 2025 | 70,000.00 |
| Sep 30, 2025 | 111,000.00 |
| Jun 30, 2025 | 130,000.00 |
| Mar 31, 2025 | 493,000.00 |
| Dec 31, 2024 | 277,000.00 |
| Sep 30, 2024 | 186,000.00 |
| Jun 30, 2024 | 247,000.00 |
| Mar 31, 2024 | 140,000.00 |
| Dec 31, 2023 | 447,000.00 |
| Dec 31, 2022 | 207,000.00 |
| Sep 30, 2022 | 296,000.00 |
| Dec 31, 2019 | 170,000.00 |
| Sep 30, 2019 | 16.00 Mn |
| Dec 31, 2018 | 161,000.00 |
Korro Bio Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=KRRO&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "KRRO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=KRRO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();